Michigan receives limited supply of oral antiviral COVID-19 medications 

Michigan received its first shipment of paxlovid and molnupiravir, new oral medications to treat COVID-19, officials confirmed Jan. 7.

Advertisement

Because of the limited quantity, the Michigan Department of Health and Human Services developed eligibility criteria and prescribing requirements, which are to remain in effect until the supply is stable.

“We ask Michiganders to be patient as providers will prioritize people at highest risk for developing serious illness from the virus,” said Elizabeth Hertel, Department of Health and Human Services director. “We are committed to distributing these pills equitably across the state, and access will increase as Michigan receives more allocations from the federal government.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.